权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Effect of HPV16 and ART on the Epigenome Leading to AIDS-Associated Oral Cancer

HPV16 和 ART 对导致艾滋病相关口腔癌的表观基因组的影响

基本信息

批准号：
9114057
负责人：
Craig M Meyers
金额：
$ 48.45万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-09-20 至 2019-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9114057
关键词：
AIDS diagnosis Acquired Immunodeficiency Syndrome Acute Adherent Culture Affect Amprenavir Annual Reports Biological Models Biology Cancer Burden Carcinogenesis Mechanism Cells Cervix Neoplasms Code Country DNA Methylation Disease Epigenetic Process Epithelial Ethnic group Gene Expression Gene Expression Regulation Genetic Genome Genomics Goals HIV HIV antiretroviral Head and Neck Squamous Cell Carcinoma Highly Active Antiretroviral Therapy Human Human Papillomavirus Human papilloma virus infection Human papillomavirus 16 Incidence Individual Infection Internet Journal of the National Cancer Institute Knowledge Life Cycle Stages Lopinavir/Ritonavir Malignant Neoplasms Malignant neoplasm of cervix uteri Measurement Measures Messenger RNA Methylation MicroRNAs Modeling Modification Molecular Molecular Abnormality Mouth Diseases Natural History Oncogenes Oncogenic Oral Oropharyngeal Pattern Persons Pharyngeal structure Premalignant Race Reporting Risk Rosa Sequence Analysis Signal Pathway Staging Testing Time Tissues Tobacco Tonsil Viral Viral Genome Virus Replication Woman antiretroviral therapy cancer site carcinogenesis differential expression epigenome epigenomics functional outcomes genome-wide keratinocyte malignant mouth neoplasm malignant oropharynx neoplasm men methylome next generation sequencing oral HPV oral HPV infection oral cavity epithelium oral tissue public health relevance reproductive tract response transcriptomics tumorigenesis viral DNA

项目摘要

DESCRIPTION (provided by applicant): The percentage of oropharyngeal cancers associated with HPV16 infection rose from 16.3% between the years of 1984 to 1989 to 71.7% between the years of 2000 to 2004. In contrast, the number of tobacco-related oropharyngeal cancers has been steadily declining over the same time period. Similar changes have been reported in multiple countries. There have been substantial changes in the burden of cancer affecting HIV- infected individuals in the U.S. during a 12-year period spanning the introduction of highly active anti-retroviral therapy (HAART). Among these emerging malignancies, HPV-associated cancers of the oral cavity/pharynx increased significantly following an AIDS diagnosis. HPV is rapidly changing the landscape of HNSCC. However, the mechanisms and natural history of oral HPV infection and oncogenic progression is poorly understood. Extrapolation of knowledge of HPV-associated oncogenicity in the genital tract is not satisfactory to our understanding of oral HPV disease. HPV is necessary, but not sufficient cause of invasive cervical cancer. The epigenetic mark of methylation is a common hallmark of human cancer. Epigenetic studies using the proper model systems can provide significant increases in our knowledge concerning the mechanisms and signaling pathways that drive HPV infection, life cycle, and oncogenesis. Aberrant microRNAs (miRNAs) expression is becoming recognized as a new molecular mechanism of carcinogenesis. HPV-infected keratinocytes express a different set of miRNAs when compared to noninfected keratinocytes. Additionally, HPV-infected cells grown in nondifferentiating monolayer culture express a different set of miRNAs compared to HPV-infected differentiating keratinocytes. Our long-term goal is to investigate the epigenetic mechanisms of HPV-associated oral disease. HPV16 is associated with 90-95% of HNSCC. Our studies will focus on HPV16. Our hypothesis is that the effect of the HPV life cycle and carcinogenesis on the epigenomic landscape of oral epithelium is further affected by HIV antiretroviral therapy (ART). The epigenome of both the host genome and the viral genome is affected. A combination of next generation sequencing analysis of the methylome and co-altered miRNA expression will be used to identify epigenetic modifications of high importance. We will test these hypotheses in three specific aims SPECIFIC AIM 1: Measure genome-wide epigenetic changes occurring at different stages of the HPV16 life cycle. SPECIFIC AIM 2: Measure genome-wide epigenetic changes occurring during HPV16 carcinogenic progression. SPECIFIC AIM 3: Delineate epigenetic modifications that occur in response to ART treatment.